Levitee Labs to Commence Trading on the Canadian Securities Exchange Under the Ticker Symbol āLVTā on Wednesday, July 21st 2021 Post published:July 19, 2021 Post category:Press Release
Octarine Bio announces the expansion of its Scientific Advisory Board Post published:July 19, 2021 Post category:Press Release
Psychedelic Bulletin: Third Psychedelics ETF Expected to Launch; Tracking Psychedelic Drug Policy Reform; One Direction for atai Post published:July 16, 2021 Post category:Psychedelic Bulletin
Nova Mentis Appoints Dr. Stephen Glazer as Director and Chief Science Officer Post published:July 15, 2021 Post category:Press Release
Red Light Holland Expected Merger Partner Creso Pharma Completes Acquisition of Halucenex Life Sciences Inc Post published:July 15, 2021 Post category:Press Release
Optimi Health Joins First Psychedelic Exchange Traded Fund Post published:July 14, 2021 Post category:Press Release
Ian Burnstein Joins Wesana Health Advisory Board Post published:July 14, 2021 Post category:Press Release
Psychedelic Research Bulletin: June 2021 Post published:July 14, 2021 Post category:Psychedelics Research Review
Awakn Life Sciences Initiates Research Program to Further Develop Ketamine-Assisted Therapies for Treating Addiction Post published:July 14, 2021 Post category:Press Release
PsyBio Therapeutics Augments Intellectual Property Portfolio with Filing of Next Novel Psychedelic Compositions and Methods of Treatment Patent Post published:July 13, 2021 Post category:Press Release